Work

158P XCR1+ dendritic cell (DC) role in antitumoral response to anti PD-L1 antibody: Data from the phase Ib/II trial of DC vaccination in small cell lung cancer patients

Year: 2024

Type: article

Abstract: OPC)

Source: Immuno-Oncology Technology

DOI: 10.1016/j.iotech.2024.100787

Authors: M. Gonzalez Cao, M. Sistere, M.T. Moran Bueno, N. Reguart, A. Meyerhans, R. Cabezon, A. Aguilar Hernandez, R. Roman, M.A. Molina-Vila, K. Birgin, E. Domenjo, G. Pique, J. Sabate, I.G. Sullivan, I. Moya Horno, L. Cirera, A. Drozdowskyj, R. Rosell, M. Juan, D. Benitez-Ribas

Institutions: Instituto Oncológico Dr. Rosell, Universitat Pompeu Fabra, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Hospital Universitario Dexeus

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,170

OpenAlex ID: W4405374612

FWCI:

Cites:

Cited by:

Related to: 10